NZ196555A - 2-(4-(hydroxy or alkanoyloxy)phenyl)-4-(4-chlorophenyl)-thiazol-5-yl acetic acids - Google Patents
2-(4-(hydroxy or alkanoyloxy)phenyl)-4-(4-chlorophenyl)-thiazol-5-yl acetic acidsInfo
- Publication number
- NZ196555A NZ196555A NZ196555A NZ19655581A NZ196555A NZ 196555 A NZ196555 A NZ 196555A NZ 196555 A NZ196555 A NZ 196555A NZ 19655581 A NZ19655581 A NZ 19655581A NZ 196555 A NZ196555 A NZ 196555A
- Authority
- NZ
- New Zealand
- Prior art keywords
- compound
- formula
- chlorophenyl
- thiazole
- acetic acid
- Prior art date
Links
- 235000011054 acetic acid Nutrition 0.000 title 1
- 125000004423 acyloxy group Chemical group 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims description 52
- 239000000203 mixture Substances 0.000 claims description 20
- 150000003839 salts Chemical class 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 125000004432 carbon atom Chemical group C* 0.000 claims description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- DJNVULSXUFPTJJ-UHFFFAOYSA-N 2-[4-(4-chlorophenyl)-2-(4-hydroxyphenyl)-1,3-thiazol-5-yl]acetic acid Chemical compound OC(=O)CC=1SC(C=2C=CC(O)=CC=2)=NC=1C1=CC=C(Cl)C=C1 DJNVULSXUFPTJJ-UHFFFAOYSA-N 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 7
- 230000000699 topical effect Effects 0.000 claims description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 5
- 125000002252 acyl group Chemical group 0.000 claims description 5
- 239000000443 aerosol Substances 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- YLCVFLYVLHOXSL-UHFFFAOYSA-N 2-[2-(4-acetyloxyphenyl)-4-(4-chlorophenyl)-1,3-thiazol-5-yl]acetic acid Chemical compound C1=CC(OC(=O)C)=CC=C1C1=NC(C=2C=CC(Cl)=CC=2)=C(CC(O)=O)S1 YLCVFLYVLHOXSL-UHFFFAOYSA-N 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052794 bromium Inorganic materials 0.000 claims description 3
- VDTNKXSVUGXUOJ-UHFFFAOYSA-N chembl2441358 Chemical compound NC(=S)C1=CC=C(O)C=C1 VDTNKXSVUGXUOJ-UHFFFAOYSA-N 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims description 3
- 238000011200 topical administration Methods 0.000 claims description 3
- IGOYRYSKKLREIH-UHFFFAOYSA-N 3-bromo-4-(4-chlorophenyl)-4-oxobutanoic acid Chemical compound OC(=O)CC(Br)C(=O)C1=CC=C(Cl)C=C1 IGOYRYSKKLREIH-UHFFFAOYSA-N 0.000 claims description 2
- AEOCXXJPGCBFJA-UHFFFAOYSA-N ethionamide Chemical compound CCC1=CC(C(N)=S)=CC=N1 AEOCXXJPGCBFJA-UHFFFAOYSA-N 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 229960004592 isopropanol Drugs 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- DKPXLGYTHAWCBA-UHFFFAOYSA-N 2-[4-(4-chlorophenyl)-2-(4-pentanoyloxyphenyl)-1,3-thiazol-5-yl]acetic acid Chemical compound C1=CC(OC(=O)CCCC)=CC=C1C1=NC(C=2C=CC(Cl)=CC=2)=C(CC(O)=O)S1 DKPXLGYTHAWCBA-UHFFFAOYSA-N 0.000 claims 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims 2
- VBZSNMAZQSQNQY-UHFFFAOYSA-N 2-[2-(4-chlorophenyl)-1,3-thiazol-5-yl]acetic acid Chemical compound S1C(CC(=O)O)=CN=C1C1=CC=C(Cl)C=C1 VBZSNMAZQSQNQY-UHFFFAOYSA-N 0.000 claims 1
- HXVXQNLFPLXVLD-UHFFFAOYSA-N 2-[4-(4-chlorophenyl)-4-hydroxy-2-(4-hydroxyphenyl)-5H-1,3-thiazol-5-yl]acetic acid Chemical compound OC(=O)CC1SC(C=2C=CC(O)=CC=2)=NC1(O)C1=CC=C(Cl)C=C1 HXVXQNLFPLXVLD-UHFFFAOYSA-N 0.000 claims 1
- AHVASTJJVAYFPY-UHFFFAOYSA-N 4-(4-chlorophenyl)-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)C1=CC=C(Cl)C=C1 AHVASTJJVAYFPY-UHFFFAOYSA-N 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- WAWAMQRRMZLXIK-UHFFFAOYSA-N methyl 2-[4-(4-chlorophenyl)-2-(4-hydroxyphenyl)-1,3-thiazol-5-yl]acetate Chemical compound COC(=O)CC=1SC(C=2C=CC(O)=CC=2)=NC=1C1=CC=C(Cl)C=C1 WAWAMQRRMZLXIK-UHFFFAOYSA-N 0.000 claims 1
- 229910000029 sodium carbonate Inorganic materials 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 8
- 239000004480 active ingredient Substances 0.000 description 6
- -1 heteroaryl radicals Chemical class 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 5
- 229960000583 acetic acid Drugs 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- 239000008247 solid mixture Substances 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 3
- KOQNISNMBYPFKQ-UHFFFAOYSA-N 2-(1,3-thiazol-5-yl)acetic acid Chemical class OC(=O)CC1=CN=CS1 KOQNISNMBYPFKQ-UHFFFAOYSA-N 0.000 description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 210000005069 ears Anatomy 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 150000003557 thiazoles Chemical class 0.000 description 2
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001266 acyl halides Chemical class 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000001669 calcium Chemical class 0.000 description 1
- 125000001589 carboacyl group Chemical group 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229940117173 croton oil Drugs 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000020335 dealkylation Effects 0.000 description 1
- 238000006900 dealkylation reaction Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical group 0.000 description 1
- 210000000548 hind-foot Anatomy 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229910000043 hydrogen iodide Inorganic materials 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940032007 methylethyl ketone Drugs 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000013223 sprague-dawley female rat Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000005556 structure-activity relationship Methods 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 239000012049 topical pharmaceutical composition Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 125000004953 trihalomethyl group Chemical group 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8011251 | 1980-04-03 | ||
| GB8013860 | 1980-04-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ196555A true NZ196555A (en) | 1984-07-06 |
Family
ID=26275077
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ196555A NZ196555A (en) | 1980-04-03 | 1981-03-18 | 2-(4-(hydroxy or alkanoyloxy)phenyl)-4-(4-chlorophenyl)-thiazol-5-yl acetic acids |
Country Status (26)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4746669A (en) * | 1985-12-23 | 1988-05-24 | Merck & Co., Inc. | Substituted thiazoles as immunoregulants |
| WO1993024472A1 (fr) * | 1992-05-29 | 1993-12-09 | Otsuka Pharmaceutical Co., Ltd. | Derive de thiazole |
| US5639770A (en) * | 1992-05-29 | 1997-06-17 | Otsuka Pharmaceutical Co., Ltd. | Thiazole derivatives |
| BR0208956A (pt) * | 2001-04-16 | 2004-07-13 | Tanabe Seiyaku Co | Abridor de canais de k ativados por cálcio de grande condutância |
| PE20060315A1 (es) * | 2004-05-24 | 2006-05-15 | Irm Llc | Compuestos de tiazol como moduladores de ppar |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR950290A (fr) * | 1944-05-18 | 1949-09-22 | Kodak Pathe | Procédé de préparation des acides 4-arylthiazol (et sélénazol)-5-acétiques et de leurs esters |
| NL130759C (cg-RX-API-DMAC10.html) * | 1965-10-07 | |||
| GB1145884A (en) | 1966-11-18 | 1969-03-19 | Wyeth John & Brother Ltd | Thiazole derivatives |
| GB1137529A (en) * | 1967-05-04 | 1968-12-27 | Wyeth John & Brother Ltd | Thiazole compositions |
| FR1561433A (cg-RX-API-DMAC10.html) * | 1968-02-12 | 1969-03-28 | ||
| GB1262292A (en) * | 1968-04-09 | 1972-02-02 | Wyeth John & Brother Ltd | Novel thiazoline derivatives, the preparation thereof and compositions containing the same |
| US3539585A (en) * | 1968-10-03 | 1970-11-10 | American Home Prod | 4-hydroxy-2-thiazoline-5-alkanoic acids |
| FR2096994A1 (en) * | 1970-07-24 | 1972-03-03 | Roussel Uclaf | 2-para-cyclopropyl phenyl-4-(halo)phenyl-5-thiazolyl - alkanoic acids -antiinflammatory analgesic, antipyretic agents |
| FR2146575A5 (cg-RX-API-DMAC10.html) * | 1971-07-20 | 1973-03-02 | Labo Braglia Spa | |
| GB1574583A (en) * | 1978-02-09 | 1980-09-10 | Wyeth John & Brother Ltd | Process for preparing thiazoles |
-
1981
- 1981-03-16 GR GR64404A patent/GR74148B/el unknown
- 1981-03-17 IL IL62400A patent/IL62400A/xx unknown
- 1981-03-18 NZ NZ196555A patent/NZ196555A/en unknown
- 1981-03-20 AU AU68604/81A patent/AU543800B2/en not_active Expired
- 1981-03-20 CA CA000373494A patent/CA1152083A/en not_active Expired
- 1981-03-20 CA CA000373568A patent/CA1154680A/en not_active Expired
- 1981-03-24 AR AR284724A patent/AR227304A1/es active
- 1981-03-25 US US06/247,461 patent/US4356185A/en not_active Expired - Lifetime
- 1981-03-25 DK DK135081A patent/DK147913C/da not_active IP Right Cessation
- 1981-03-25 US US06/247,460 patent/US4385059A/en not_active Expired - Lifetime
- 1981-03-27 PT PT72756A patent/PT72756B/pt unknown
- 1981-03-31 ES ES500909A patent/ES500909A0/es active Granted
- 1981-03-31 PH PH25451D patent/PH16437A/en unknown
- 1981-03-31 PH PH25451A patent/PH16493A/en unknown
- 1981-04-01 LU LU83273A patent/LU83273A1/fr unknown
- 1981-04-01 CH CH2221/81A patent/CH652715A5/fr not_active IP Right Cessation
- 1981-04-02 AT AT81301428T patent/ATE8779T1/de active
- 1981-04-02 IN IN367/CAL/81A patent/IN151559B/en unknown
- 1981-04-02 YU YU874/81A patent/YU42391B/xx unknown
- 1981-04-02 DE DE8181301428T patent/DE3165175D1/de not_active Expired
- 1981-04-02 FR FR8106620A patent/FR2479820A1/fr active Granted
- 1981-04-02 EP EP81301428A patent/EP0037710B1/en not_active Expired
- 1981-04-02 IT IT20901/81A patent/IT1144691B/it active
- 1981-04-02 IE IE760/81A patent/IE51132B1/en not_active IP Right Cessation
- 1981-04-02 PL PL1981230483A patent/PL129322B1/pl unknown
- 1981-04-02 KR KR1019810001113A patent/KR850000011B1/ko not_active Expired
- 1981-04-02 FI FI811019A patent/FI73985C/fi not_active IP Right Cessation
- 1981-04-02 DO DO1981002974A patent/DOP1981002974A/es unknown
- 1981-04-02 NO NO811134A patent/NO154965C/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3538107A (en) | Aryl-thiazolyl-acetic acid derivatives | |
| US4062966A (en) | 1-Aryl-2-(1-imidazolyl) alkyl ethers and thioethers | |
| CZ382692A3 (en) | Chemical compounds | |
| US3649679A (en) | Substituted phenylalkanoic acid derivatives ii | |
| JPS6052147B2 (ja) | イミダゾリルビニルエ−テル、それの酸附加塩及びそれの製造方法 | |
| US4188397A (en) | 2,2-Alkyldiylbis(thio)bis(imidazoles) | |
| NZ196555A (en) | 2-(4-(hydroxy or alkanoyloxy)phenyl)-4-(4-chlorophenyl)-thiazol-5-yl acetic acids | |
| US4234742A (en) | Bis-(aryloxycarboxylic acid) compounds | |
| US4337259A (en) | Pyridine derivatives | |
| EP0592664B1 (en) | Derivatives of diphenylthiazole with antiinflammatory activity | |
| GB2073194A (en) | 2,4-diaryl Thiazol-5-yl-acetic Acids | |
| US4115402A (en) | 2,3-Dichloro-4-[(substituted-sulfonyl)-phenoxy]-acetic acids | |
| US4255575A (en) | 2-Hydroxy-5-(1-hydroxy-2-piperazinylethyl)-benzoic acid derivatives | |
| US4025528A (en) | Thiazole derivatives of benzoic and phenylalkanoic acids | |
| EP0079639B1 (en) | A new anti-inflammatory drug | |
| US4376788A (en) | Basic ethers of 4-hydroxy-benzophenones acting as beta-blocking agents | |
| JPS6363670A (ja) | ド−パミン−β−ヒドロキシラ−ゼ抑制剤 | |
| US4128550A (en) | 1-Methyl-4-piperidyl 5-phenyl-2-furoates | |
| US3920668A (en) | Antiphlogistic 1-(hydroxy or carboxylic acyloxy)-3-(2{40 -halo-4-biphenylyl) | |
| US4077968A (en) | Thiazole derivatives | |
| US3558626A (en) | 2-(4 - (diphenyl-2-pyrimidinyl)phenoxy) lower aliphatic monocarbocyclic acids and esters | |
| US4042594A (en) | The hypolipidemic agent, 4-(4-chlorobenzyloxy)-benzyl nicotinate and preparation thereof | |
| US4415579A (en) | Pyridine derivatives | |
| US4192884A (en) | Substituted 4-(((thienyl)methyl)-amino)benzoic acids and a method for treating hypolipidemia | |
| CA1208630A (en) | Ergot derivatives |